AXL and neoplasm: In vivo, the effect of targeting Axl in FAKKO pericytes was tested by co-injecting wildtype C57bl6 mice with B16F0 tumour cells and either FAK-null;AxlKO, FAK-null;Cas9 or WT;Cas9 control pericytes.